{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:32:18Z","timestamp":1791048738137,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunosuppressive tumor microenvironment is a crucial factor that impedes the success of tumor immunotherapy, and tumor-associated macrophages (TAMs) are essential for the formation of tumor immunosuppressive microenvironment. Hyaluronic acid (HA) is highly important brick for glioblastoma microenvironment, but whether it contributes to TAM polarization and glioblastoma immunosuppressive microenvironment is less well known. In our study, we observed that disrupting glioblastoma HA synthesis or blocking HA binding to its receptor CD44 on macrophages increased the proportion of M1 macrophages by upregulating SIRP\u03b1 in macrophages, the underlying mechanism was elevated SIRP\u03b1 enhanced STAT1 phosphorylation and suppressed STAT3 phosphorylation in macrophages. Subsequently, the induced macrophages could inhibit glioblastoma growth via a feedback effect. In addition, 4-methylumbelliferone (4MU), a cholecystitis drug, can disrupt the CD47\/SIRP\u03b1 axis by disturbing glioblastoma HA synthesis. Collectively, these findings indicated that HA plays a crucial role in macrophages polarization and CD47\/SIRP\u03b1 signaling between glioblastoma cells and macrophages, and suppressing the HA pathway may be a new immunotherapeutic approach for glioblastoma.<\/jats:p>","DOI":"10.1038\/s41420-022-00973-y","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T10:02:59Z","timestamp":1649671379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Suppression of the hyaluronic acid pathway induces M1 macrophages polarization via STAT1 in glioblastoma"],"prefix":"10.1038","volume":"8","author":[{"given":"Tao","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaikai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0766-4809","authenticated-orcid":false,"given":"Huailei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"973_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","volume":"560","author":"JH Lee","year":"2018","unstructured":"Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature. 2018;560:243\u2013247.","journal-title":"Nature"},{"key":"973_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","volume":"14","author":"JJ Luke","year":"2017","unstructured":"Luke JJ, Flaherty KT, Ribas A, Long GV. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol. 2017;14:463\u2013482.","journal-title":"Nat Rev Clin Oncol."},{"key":"973_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ctrv.2019.03.004","volume":"75","author":"C Proto","year":"2019","unstructured":"Proto C, Ferrara R, Signorelli D, Lo Russo G, Galli G, Imbimbo M, et al. Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out. Cancer Treat Rev. 2019;75:39\u201351.","journal-title":"Cancer Treat Rev."},{"key":"973_CR4","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.3389\/fimmu.2018.02924","volume":"9","author":"Q Ma","year":"2018","unstructured":"Ma Q, Long W, Xing C, Chu J, Luo M, Wang HY, et al. Cancer stem cells and immunosuppressive microenvironment in glioma. Front Immunol. 2018;9:2924.","journal-title":"Front Immunol."},{"key":"973_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.12527","volume":"276","author":"HL Matlung","year":"2017","unstructured":"Matlung HL, Szilagyi K, Barclay NA, van den Berg TK. The CD47-SIRPalpha signaling axis as an innate immune checkpoint in cancer. Immunol Rev. 2017;276:145\u2013164.","journal-title":"Immunol Rev."},{"key":"973_CR6","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","volume":"184","author":"ND Mathewson","year":"2021","unstructured":"Mathewson ND, Ashenberg O, Tirosh I, Gritsch S, Perez EM, Marx S, et al. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell. 2021;184:1281\u20131298 e1226.","journal-title":"Cell"},{"key":"973_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12:76.","journal-title":"J Hematol Oncol."},{"key":"973_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","volume":"114","author":"C Ngambenjawong","year":"2017","unstructured":"Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev. 2017;114:206\u2013221.","journal-title":"Adv Drug Deliv Rev."},{"key":"973_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/neuonc\/noaa215.933","volume":"22","author":"J Wei","year":"2020","unstructured":"Wei J, Chen P, Gupta P, Ott M, Zamler D, Kassab C, et al. Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications. Neuro Oncol. 2020;22:180\u2013194.","journal-title":"Neuro Oncol."},{"key":"973_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/path.2370","volume":"216","author":"Y Komohara","year":"2008","unstructured":"Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol. 2008;216:15\u201324.","journal-title":"J Pathol."},{"key":"973_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.canlet.2017.10.037","volume":"413","author":"RT Netea-Maier","year":"2018","unstructured":"Netea-Maier RT, Smit JWA, Netea MG. Metabolic changes in tumor cells and tumor-associated macrophages: a mutual relationship. Cancer Lett. 2018;413:102\u2013109.","journal-title":"Cancer Lett."},{"key":"973_CR12","doi-asserted-by":"publisher","first-page":"593219","DOI":"10.3389\/fimmu.2020.593219","volume":"11","author":"J Hu","year":"2020","unstructured":"Hu J, Xiao Q, Dong M, Guo D, Wu X, Wang B. Glioblastoma immunotherapy targeting the innate immune checkpoint CD47-SIRPalpha axis. Front Immunol. 2020;11:593219.","journal-title":"Front Immunol."},{"key":"973_CR13","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1158\/0008-5472.CAN-18-3125","volume":"79","author":"D Ma","year":"2019","unstructured":"Ma D, Liu S, Lal B, Wei S, Wang S, Zhan D, et al. Extracellular matrix protein tenascin C increases phagocytosis mediated by CD47 loss of function in glioblastoma. Cancer Res. 2019;79:2697\u20132708.","journal-title":"Cancer Res"},{"key":"973_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2016.02.031","volume":"375","author":"T Chanmee","year":"2016","unstructured":"Chanmee T, Ontong P, Itano N. Hyaluronan: a modulator of the tumor microenvironment. Cancer Lett. 2016;375:20\u201330.","journal-title":"Cancer Lett."},{"key":"973_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/B978-0-12-800092-2.00002-2","volume":"123","author":"VB Lokeshwar","year":"2014","unstructured":"Lokeshwar VB, Mirza S, Jordan A. Targeting hyaluronic acid family for cancer chemoprevention and therapy. Adv Cancer Res. 2014;123:35\u201365.","journal-title":"Adv Cancer Res"},{"key":"973_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.semcancer.2019.07.007","volume":"62","author":"I Caon","year":"2020","unstructured":"Caon I, Bartolini B, Parnigoni A, Carava E, Moretto P, Viola M, et al. Revisiting the hallmarks of cancer: the role of hyaluronan. Semin Cancer Biol. 2020;62:9\u201319.","journal-title":"Semin Cancer Biol."},{"key":"973_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/his.12607","volume":"66","author":"S Tiainen","year":"2015","unstructured":"Tiainen S, Tumelius R, Rilla K, Hamalainen K, Tammi M, Tammi R, et al. High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer. Histopathology. 2015;66:873\u2013883.","journal-title":"Histopathology"},{"key":"973_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1385\/IR:31:3:189","volume":"31","author":"ME Mummert","year":"2005","unstructured":"Mummert ME. Immunologic roles of hyaluronan. Immunol Res. 2005;31:189\u2013206.","journal-title":"Immunol Res."},{"key":"973_CR19","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/eji.201040870","volume":"41","author":"N Maeshima","year":"2011","unstructured":"Maeshima N, Poon GF, Dosanjh M, Felberg J, Lee SS, Cross JL, et al. Hyaluronan binding identifies the most proliferative activated and memory T cells. Eur J Immunol. 2011;41:1108\u20131119.","journal-title":"Eur J Immunol."},{"key":"973_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03747-z","volume":"12","author":"T Yan","year":"2021","unstructured":"Yan T, Chen X, Zhan H, Yao P, Wang N, Yang H, et al. Interfering with hyaluronic acid metabolism suppresses glioma cell proliferation by regulating autophagy. Cell Death Dis. 2021;12:486.","journal-title":"Cell Death Dis."},{"key":"973_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1152\/physrev.00052.2009","volume":"91","author":"D Jiang","year":"2011","unstructured":"Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011;91:221\u2013264.","journal-title":"Physiol Rev."},{"key":"973_CR22","doi-asserted-by":"crossref","unstructured":"Medvedeva GF, Kuzmina DO, Nuzhina J, Shtil AA, Dukhinova MS. How macrophages become transcriptionally dysregulated: a hidden impact of antitumor therapy. Int J Mol Sci. 2021, 22.","DOI":"10.3390\/ijms22052662"},{"key":"973_CR23","doi-asserted-by":"publisher","first-page":"9294018","DOI":"10.1155\/2017\/9294018","volume":"2017","author":"GJ Szebeni","year":"2017","unstructured":"Szebeni GJ, Vizler C, Kitajka K, Puskas LG. Inflammation and cancer: extra- and intracellular determinants of tumor-associated macrophages as tumor promoters. Mediators Inflamm. 2017;2017:9294018.","journal-title":"Mediators Inflamm."},{"key":"973_CR24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41388-019-0996-y","volume":"39","author":"M Qian","year":"2020","unstructured":"Qian M, Wang S, Guo X, Wang J, Zhang Z, Qiu W, et al. Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-kappaB pathways. Oncogene. 2020;39:428\u2013442.","journal-title":"Oncogene"},{"key":"973_CR25","first-page":"123","volume":"6","author":"N Nagy","year":"2015","unstructured":"Nagy N, Kuipers HF, Frymoyer AR, Ishak HD, Bollyky JB, Wight TN, et al. 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Front Immunol. 2015;6:123.","journal-title":"Front Immunol."},{"key":"973_CR26","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1016\/j.ymthe.2018.09.012","volume":"26","author":"MM Rodriguez","year":"2018","unstructured":"Rodriguez MM, Fiore E, Bayo J, Atorrasagasti C, Garcia M, Onorato A, et al. 4Mu decreases CD47 expression on hepatic cancer stem cells and primes a potent antitumor T cell response induced by interleukin-12. Mol Ther. 2018;26:2738\u20132750.","journal-title":"Mol Ther."},{"key":"973_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.biomaterials.2017.01.004","volume":"121","author":"E Koh","year":"2017","unstructured":"Koh E, Lee EJ, Nam GH, Hong Y, Cho E, Yang Y, et al. Exosome-SIRPalpha, a CD47 blockade increases cancer cell phagocytosis. Biomaterials. 2017;121:121\u2013129.","journal-title":"Biomaterials"},{"key":"973_CR28","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1158\/1078-0432.CCR-17-3284","volume":"24","author":"X Li","year":"2018","unstructured":"Li X, Shepard HM, Cowell JA, Zhao C, Osgood RJ, Rosengren S, et al. Parallel accumulation of tumor hyaluronan, collagen, and other drivers of tumor progression. Clin Cancer Res. 2018;24:4798\u20134807.","journal-title":"Clin Cancer Res"},{"key":"973_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/B978-0-12-800092-2.00004-6","volume":"123","author":"D Vigetti","year":"2014","unstructured":"Vigetti D, Passi A. Hyaluronan synthases posttranslational regulation in cancer. Adv Cancer Res. 2014;123:95\u2013119.","journal-title":"Adv Cancer Res"},{"key":"973_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.addr.2015.10.017","volume":"97","author":"J Liang","year":"2016","unstructured":"Liang J, Jiang D, Noble PW. Hyaluronan as a therapeutic target in human diseases. Adv Drug Deliv Rev. 2016;97:186\u2013203.","journal-title":"Adv Drug Deliv Rev."},{"key":"973_CR31","doi-asserted-by":"crossref","unstructured":"Prasad A, Manoharan RR, Sedlarova M, Pospisil P. Free radical-mediated protein radical formation in differentiating monocytes. Int J Mol Sci. 2021, 22.","DOI":"10.3390\/ijms22189963"},{"key":"973_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03664-1","volume":"12","author":"J Xu","year":"2021","unstructured":"Xu J, Zhang J, Zhang Z, Gao Z, Qi Y, Qiu W, et al. Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction. Cell Death Dis. 2021;12:373.","journal-title":"Cell Death Dis."},{"key":"973_CR33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/cm.20544","volume":"68","author":"LY Bourguignon","year":"2011","unstructured":"Bourguignon LY, Wong G, Earle CA, Xia W. Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFkappaB signaling leading to proinflammatory cytokine\/chemokine production and breast tumor invasion. Cytoskeleton (Hoboken). 2011;68:671\u2013693.","journal-title":"Cytoskeleton (Hoboken)"},{"key":"973_CR34","doi-asserted-by":"publisher","first-page":"e1172154","DOI":"10.1080\/2162402X.2016.1172154","volume":"5","author":"G Zhang","year":"2016","unstructured":"Zhang G, Guo L, Yang C, Liu Y, He Y, Du Y, et al. A novel role of breast cancer-derived hyaluronan on inducement of M2-like tumor-associated macrophages formation. Oncoimmunology. 2016;5:e1172154.","journal-title":"Oncoimmunology"},{"key":"973_CR35","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1039\/C9BM00155G","volume":"7","author":"H Kim","year":"2019","unstructured":"Kim H, Cha J, Jang M, Kim P. Hyaluronic acid-based extracellular matrix triggers spontaneous M2-like polarity of monocyte\/macrophage. Biomater Sci. 2019;7:2264\u20132271.","journal-title":"Biomater Sci."},{"key":"973_CR36","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nri3088","volume":"11","author":"T Lawrence","year":"2011","unstructured":"Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11:750\u2013761.","journal-title":"Nat Rev Immunol."},{"key":"973_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122:787\u2013795.","journal-title":"J Clin Invest"},{"key":"973_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejca.2017.02.013","volume":"76","author":"K Weiskopf","year":"2017","unstructured":"Weiskopf K. Cancer immunotherapy targeting the CD47\/SIRPalpha axis. Eur J Cancer. 2017;76:100\u2013109.","journal-title":"Eur J Cancer"},{"key":"973_CR39","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/hep.26391","volume":"58","author":"YF Pan","year":"2013","unstructured":"Pan YF, Tan YX, Wang M, Zhang J, Zhang B, Yang C, et al. Signal regulatory protein alpha is associated with tumor-polarized macrophages phenotype switch and plays a pivotal role in tumor progression. Hepatology. 2013;58:680\u2013691.","journal-title":"Hepatology"},{"key":"973_CR40","doi-asserted-by":"publisher","first-page":"22888","DOI":"10.1074\/jbc.M114.559583","volume":"289","author":"AM Mueller","year":"2014","unstructured":"Mueller AM, Yoon BH, Sadiq SA. Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS. J Biol Chem. 2014;289:22888\u201322899.","journal-title":"J Biol Chem."},{"key":"973_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.matbio.2018.04.007","volume":"78-79","author":"TT Karalis","year":"2019","unstructured":"Karalis TT, Heldin P, Vynios DH, Neill T, Buraschi S, Iozzo RV, et al. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: regulation of hyaluronan\/HAS2\/CD44 and specific matrix effectors. Matrix Biol. 2019;78-79:118\u2013138.","journal-title":"Matrix Biol."}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00973-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00973-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00973-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T10:26:21Z","timestamp":1669285581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00973-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1038\/s41420-022-00973-y","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"30 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics of this research was allowed by the Ethics Committee of First Affiliated Hospital of Harbin Medical University and accorded with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"193"}}